QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

NCT03169764 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Trial not initiated

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

BIOLOGICAL: Avelumab
BIOLOGICAL: Bevacizumab
DRUG: Capecitabine
BIOLOGICAL: Cetuximab
DRUG: Cisplatin
DRUG: cyclophosphamide
DRUG: 5-Fluorouracil (5-FU)
DRUG: fulvestrant
DRUG: leucovorin
DRUG: nab-paclitaxel
BIOLOGICAL: nivolumab
DRUG: Lovaza
RADIATION: Stereotactic Body Radiation Therapy
BIOLOGICAL: ALT-803
BIOLOGICAL: ETBX-011
BIOLOGICAL: ETBX-021
BIOLOGICAL: ETBX-051
BIOLOGICAL: ETBX-061
BIOLOGICAL: GI-4000
BIOLOGICAL: GI-6207

Sponsor

ImmunityBio, Inc.